We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PEPLW
426
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$7.08K ﹤0.01%
235,067
+51,172
+28% +$1.26K
SKGRW
427
DELISTED
SK Growth Opportunities Corporation Warrant
SKGRW
$7K ﹤0.01%
100,000
-2,800
-3% -$153
GAQ.WS
428
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
$6.99K ﹤0.01%
233,066
-1,700
-0.7% -$60
FRLAW
429
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$6.98K ﹤0.01%
174,530
+51,726
+42% +$1.99K
ALSAW
430
DELISTED
Alpha Star Acquisition Corp Warrants
ALSAW
$6.81K ﹤0.01%
642,224
SWSSW
431
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
$6.63K ﹤0.01%
88,417
-4,000
-4% -$359
TGVCW
432
DELISTED
TG Venture Acquisition Corp. Warrants
TGVCW
$6.61K ﹤0.01%
446,435
+17,718
+4% +$397
CAPTW
433
DELISTED
Captivision Inc Warrant
CAPTW
$6.59K ﹤0.01%
+82,347
New +$7.62K
SVIIR
434
DELISTED
Spring Valley Acquisition Corp II Rights
SVIIR
$6.57K ﹤0.01%
46,900
-500
-1% -$57
VEEAW
435
Veea Inc Warrant
VEEAW
$504K
$6.54K ﹤0.01%
+46,789
New +$4.67K
GATEW
436
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$6.54K ﹤0.01%
+217,948
New +$6.08K
RMGCW
437
DELISTED
RMG Acquisition Corp. III Warrant
RMGCW
$6.5K ﹤0.01%
100,000
-57,636
-37% -$3.84K
HHGCR
438
DELISTED
HHG Capital Corporation Rights
HHGCR
$6.38K ﹤0.01%
50,000
-19,112
-28% -$2.91K
XAGEW
439
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$6.25K ﹤0.01%
25,000
-175,000
-88% -$29.9K
OPA.WS
440
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$6.24K ﹤0.01%
369,415
-13,500
-4% -$342
GRMLW
441
Greenland Mines Ltd Warrant
GRMLW
$6.24K ﹤0.01%
276,110
+12,598
+5% +$370
PRLHW
442
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$6.17K ﹤0.01%
153,775
+200
+0.1% +$6
EVGRW
443
DELISTED
Evergreen Corporation Warrant
EVGRW
$6.03K ﹤0.01%
300,000
-195,560
-39% -$5.16K
ABVEW
444
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$6.01K ﹤0.01%
200,404
-11,638
-5% -$491
BNAIW
445
Brand Engagement Network Warrant
BNAIW
$2.14M
$5.98K ﹤0.01%
298,909
-44,514
-13% -$1.62K
MNTSW icon
446
Momentus Inc Warrant
MNTSW
$9
$5.96K ﹤0.01%
596,475
-15,900
-3% -$307
SHFSW icon
447
SHF Holdings Warrants
SHFSW
$241K
$5.86K ﹤0.01%
69,931
SNAXW
448
DELISTED
Stryve Foods, Inc. Warrant
SNAXW
$5.83K ﹤0.01%
972,666
+6
+0%
INVZW
449
DELISTED
Innoviz Technologies Warrant
INVZW
$5.66K ﹤0.01%
11,719
-739,996
-98% -$382K
CCGWW
450
Cheche Group Inc Warrant
CCGWW
$5.6K ﹤0.01%
100,050
+50
+0.1% +$5

Similar funds

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.